Piza F, Fritsch A, Funovics J, Kretschmer G, Mühlbacher F, Rauhs R, Roth E, Steininger R, Mauritz W, Sporn P
Wien Klin Wochenschr. 1985 Sep 27;97(18):714-9.
21 cases of transplantation of the liver are analysed for indication, anaesthesia, operative management, anhepatic period, immunological therapy and specific post-operative problems (jaundice and rejection episodes). Causes of death are noted and prediction of survival gives a rate of 55%/1st year in the 17 patients operated on since 1982 under a standardised management schedule. The transplantation programme in Vienna provides routine treatment for otherwise untreatable primary (57% cases) and secondary metastatic (14%) tumours of the liver, and, in the second place, for end-stage hepatic cirrhosis (14%) and certain rare liver diseases (14%).
对21例肝移植病例进行了分析,内容涉及适应证、麻醉、手术管理、无肝期、免疫治疗及术后特定问题(黄疸和排斥反应)。记录了死亡原因,自1982年以来按照标准化管理方案接受手术的17例患者的1年生存率预测为55%。维也纳的肝移植项目为无法用其他方法治疗的原发性肝癌(57%的病例)和继发性转移性肝癌(14%)提供常规治疗,其次是终末期肝硬化(14%)和某些罕见肝病(14%)。